Skip to main content

Advertisement

SpringerLink
Log in

A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma

  • Head and Neck
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Background

Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous disease characterized by different molecular subtypes with different prognosis and response to treatment. Therefore, the aim of this study was to construct reliable gene signatures based on immune checkpoint-related genes to distinguish between subgroups of patients with different risks.

Methods

We obtained the HNSCC data from The Cancer Genome Atlas (TCGA) database and Gene Expression Omnibus (GEO) as a training set and the external validation set, respectively. First, differentially expressed immune checkpoint-related genes in tumor tissues and normal tissues were determined, and the potential functions of differential genes were explored through GO function annotation and KEGG pathway enrichment analysis. Using univariate Cox regression analysis, 20 immune checkpoint-related genes in HNSCC patients were significantly associated with overall survival (OS). Subsequently, seven genes were selected by multivariate Cox regression analysis to create a gene signature. Next, the stability of gene signatures was assessed using Kaplan–Meier curve, Time-dependent receiver operating characteristic (ROC) curve. Finally, we constructed a nomogram visualization modelled to facilitate subsequent clinical applications.

Results

A total of 80 differentially expressed genes (DEGs) were obtained, the GO analysis of these DEGs indicated that they were significantly enriched in positive regulation of cell activation, T cell activation; the KEGG analysis results performed and showed that the DEGs were enriched in the MAPK signaling pathway, PI3K − Akt signaling pathway. 7 genes (PPP2R1B, MYD88, CD86, CD80, MAP2K1, TRIB3 and ICOS) were screened by univariate and multivariate Cox regression, and they were used to construct a prognostic model. In the TCGA and GEO datasets, Kaplan–Meier analysis indicated that patients in the high-risk group have a poor prognosis. The sensitivity and specificity evaluation of prognostic model for 1-, 3-, 5-year OS in TCGA were 0.644, 0.661 and 0.625, respectively; and in GSE41613 were 0.748, 0.719, and 0.727, respectively. The calibration chart curve showed that the nomogram has strong clinical performance in the prognosis prediction of HNSCC patients.

Conclusions

A novel immune checkpoint-related gene signature can effectively predict and stratify OS in HNSCC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Availability of data and materials

The raw data of this study are derived from the TCGA database (https://portal.gdc.cancer.gov/) and GEO data portal (https://www.ncbi.nlm.nih.gov/geo/), which are publicly available databases.

References

  1. Kobayashi K, Hisamatsu K, Suzui N, Hara A, Tomita H, Miyazaki T (2018) A review of HPV-related head and neck cancer. J Clin Med 7:9. https://doi.org/10.3390/jcm7090241

    Article  CAS  Google Scholar 

  2. Chow LQM (2020) Head and neck cancer. New England J Med 382(1):60–72. https://doi.org/10.1056/NEJMra1715715

    Article  CAS  Google Scholar 

  3. Argiris A, Karamouzis MV, Raben D, Ferris RL (2008) Head and neck cancer. Lancet (London, England) 371(9625):1695–1709. https://doi.org/10.1016/s0140-6736(08)60728-x

    Article  CAS  Google Scholar 

  4. Siegel RL, Miller KD, Jemal A (2017) Cancer statistics. CA Cancer J Clin 67(1):7–30. https://doi.org/10.3322/caac.21387

    Article  PubMed  Google Scholar 

  5. Meucci S, Keilholz U, Tinhofer I, Ebner OA (2016) Mutational load and mutational patterns in relation to age in head and neck cancer. Oncotarget 7(43):69188–69199. https://doi.org/10.18632/oncotarget.11312

    Article  PubMed  PubMed Central  Google Scholar 

  6. Mandal R, Şenbabaoğlu Y, Desrichard A, Havel JJ, Dalin MG, Riaz N, Lee KW, Ganly I, Hakimi AA, Chan TA, Morris LG (2016) The head and neck cancer immune landscape and its immunotherapeutic implications. JCI Insight 1(17):e89829. https://doi.org/10.1172/jci.insight.89829

    Article  PubMed  PubMed Central  Google Scholar 

  7. Mehra R, Seiwert TY, Gupta S, Weiss J, Gluck I, Eder JP, Burtness B, Tahara M, Keam B, Kang H, Muro K, Geva R, Chung HC, Lin CC, Aurora-Garg D, Ray A, Pathiraja K, Cheng J, Chow LQM, Haddad R (2018) Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012. Br J Cancer 119(2):153–159. https://doi.org/10.1038/s41416-018-0131-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Lydiatt WM, Patel SG, Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, Loomis AM, Shah JP (2017) Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin 67(2):122–137

    Article  PubMed  Google Scholar 

  9. Bobdey S, Mair M, Nair S, Nair D, Balasubramaniam G, Chaturvedi P (2018) A Nomogram based prognostic score that is superior to conventional TNM staging in predicting outcome of surgically treated T4 buccal mucosa cancer: time to think beyond TNM. Oral Oncol 81:10–15. https://doi.org/10.1016/j.oraloncology.2018.04.002

    Article  PubMed  Google Scholar 

  10. Almendro V, Marusyk A, Polyak K (2013) Cellular heterogeneity and molecular evolution in cancer. Ann Rev Pathol 8:277–302. https://doi.org/10.1146/annurev-pathol-020712-163923

    Article  CAS  Google Scholar 

  11. Mroz EA, Tward AD, Hammon RJ, Ren Y, Rocco JW (2015) Intra-tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the Cancer Genome Atlas. PLoS Med 12(2):e1001786. https://doi.org/10.1371/journal.pmed.1001786

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Liu F, Huang J, He F, Ma X, Fan F, Meng M, Zhuo Y, Zhang L (2020) CD96, a new immune checkpoint, correlates with immune profile and clinical outcome of glioma. Scient Rep 10(1):10768. https://doi.org/10.1038/s41598-020-66806-z

    Article  CAS  Google Scholar 

  13. Zhang Z, Liu J, Zhang C, Li F, Li L, Wang D, Chand D, Guan F, Zang X, Zhang Y (2020) Over-expression and prognostic significance of HHLA2, a new immune checkpoint molecule, in human clear cell renal cell carcinoma. Front Cell Dev Biol 8:280. https://doi.org/10.3389/fcell.2020.00280

    Article  PubMed  PubMed Central  Google Scholar 

  14. Scandiuzzi L, Ghosh K, Zang X (2011) T cell costimulation and coinhibition: genetics and disease. Discov Med 12(63):119–128

    PubMed  PubMed Central  Google Scholar 

  15. Shan N, Li N, Dai Q, Hou L, Yan X, Amei A, Lu L, Wang Z (2020) Interplay of tRNA-derived fragments and T cell activation in breast cancer patient survival. Cancers 12:8. https://doi.org/10.3390/cancers12082230

    Article  CAS  Google Scholar 

  16. Xie X, Xiong G, Wang Q, Ge Y, Cui X (2019) Long non-coding RNA LINC00460 promotes head and neck squamous cell carcinoma cell progression by sponging miR-612 to up-regulate AKT2. Am J Trans Res 11(10):6326–6340

    CAS  Google Scholar 

  17. Zhao ZJ, Liu FY, Li P, Ding X, Zong ZH, Sun CF (2011) CCL19-induced chemokine receptor 7 activates the phosphoinositide-3 kinase-mediated invasive pathway through Cdc42 in metastatic squamous cell carcinoma of the head and neck. Oncol Rep 25(3):729–737. https://doi.org/10.3892/or.2010.1109

    Article  CAS  PubMed  Google Scholar 

  18. Ji X, Guo X, Wang Y, Li X, Li H (2020) Rab18 regulates proliferation, invasion and cisplatin sensitivity through STAT3 signaling in head and neck squamous cell carcinoma. OncoTargets Thera 13:4123–4134. https://doi.org/10.2147/ott.S238503

    Article  CAS  Google Scholar 

  19. Chen L, Li YC, Wu L, Yu GT, Zhang WF, Huang CF, Sun ZJ (2018) TRAF6 regulates tumour metastasis through EMT and CSC phenotypes in head and neck squamous cell carcinoma. J Cell Mol Med 22(2):1337–1349. https://doi.org/10.1111/jcmm.13439

    Article  CAS  PubMed  Google Scholar 

  20. Ju H, Hu Z, Lu Y, Wu Y, Zhang L, Wei D, Guo W, Xia W, Liu S, Ren G, Hu J (2020) TLR4 activation leads to anti-EGFR therapy resistance in head and neck squamous cell carcinoma. Am J Cancer Res 10(2):454–472

    CAS  PubMed  PubMed Central  Google Scholar 

  21. García-Escudero R, Segrelles C, Dueñas M, Pombo M, Ballestín C, Alonso-Riaño M, Nenclares P, Álvarez-Rodríguez R, Sánchez-Aniceto G, Ruíz-Alonso A, López-Cedrún JL, Paramio JM, Lorz C (2018) Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway. Oral Oncol 79:55–63. https://doi.org/10.1016/j.oraloncology.2018.02.014

    Article  CAS  PubMed  Google Scholar 

  22. El Taweel M, Gawdat RM, Abdelfattah R (2020) Prognostic Impact of PPP2R5C Gene Expression in Adult Acute Myeloid Leukemia Patients with Normal Cytogenetics. Indian J Hematol Blood Trans Soc 36(1):37–46. https://doi.org/10.1007/s12288-019-01142-5

    Article  Google Scholar 

  23. Tian H, Yin L, Ding K, Xia YY, Wang XH, Wu JZ, He X (2018) Raf1 is a prognostic factor for progression in patients with non-small cell lung cancer after radiotherapy. Oncol Rep 39(4):1966–1974. https://doi.org/10.3892/or.2018.6277

    Article  CAS  PubMed  Google Scholar 

  24. Hu JW, Ding GY, Fu PY, Tang WG, Sun QM, Zhu XD, Shen YH, Zhou J, Fan J, Sun HC, Huang C (2020) Identification of FOS as a candidate risk gene for liver cancer by integrated bioinformatic analysis. Biomed Res Int 20:6784138. https://doi.org/10.1155/2020/6784138

    Article  CAS  Google Scholar 

  25. Zhou Y, Chen P, Huang Q, Wan T, Jiang Y, Jiang S, Yan S, Zheng M (2020) Overexpression of YES1 is associated with favorable prognosis and increased platinum-sensitivity in patients with epithelial ovarian cancer. Histol Histopathol 35(7):721–728. https://doi.org/10.14670/hh-18-203

    Article  CAS  PubMed  Google Scholar 

  26. Wang SS, Esplin ED, Li JL, Huang L, Gazdar A, Minna J, Evans GA (1998) Alterations of the PPP2R1B gene in human lung and colon cancer. Science (New York, NY) 282(5387):284–287. https://doi.org/10.1126/science.282.5387.284

    Article  CAS  Google Scholar 

  27. Koch AT, Love-Homan L, Espinosa-Cotton M, Stanam A, Simons AL (2015) MyD88-dependent signaling decreases the antitumor efficacy of epidermal growth factor receptor inhibition in head and neck cancer cells. Can Res 75(8):1657–1667. https://doi.org/10.1158/0008-5472.Can-14-2061

    Article  CAS  Google Scholar 

  28. Mansour A, Elkhodary T, Darwish A, Mabed M (2014) Increased expression of costimulatory molecules CD86 and sCTLA-4 in patients with acute lymphoblastic leukemia. Leukemia Lymphoma 55(9):2120–2124. https://doi.org/10.3109/10428194.2013.869328

    Article  CAS  PubMed  Google Scholar 

  29. Feng XY, Lu L, Wang KF, Zhu BY, Wen XZ, Peng RQ, Ding Y, Li DD, Li JJ, Li Y, Zhang XS (2019) Low expression of CD80 predicts for poor prognosis in patients with gastric adenocarcinoma. Future Oncol (London, England) 15(5):473–483. https://doi.org/10.2217/fon-2018-0420

    Article  CAS  Google Scholar 

  30. Huynh H, Nguyen TT, Chow KH, Tan PH, Soo KC, Tran E (2003) Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis. BMC Gastroenterol 3:19. https://doi.org/10.1186/1471-230x-3-19

    Article  PubMed  PubMed Central  Google Scholar 

  31. Wang XJ, Li FF, Zhang YJ, Jiang M, Ren WH (2020) TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis. Cancer Bio Section A Dis Markers. https://doi.org/10.3233/cbm-201577

    Article  Google Scholar 

  32. Zhang Y, Luo Y, Qin SL, Mu YF, Qi Y, Yu MH, Zhong M (2016) The clinical impact of ICOS signal in colorectal cancer patients. Oncoimmunology 5(5):e1141857. https://doi.org/10.1080/2162402x.2016.1141857

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

None.

Author information

Author notes

  1. Daoliang Song and Jie Tian contributed equally to this work.

Authors and Affiliations

  1. Department of Otorhinolaryngology, Zibo Central Hospital, No.54, Communist Youth League West Road, Zhangdian District, Zibo City, Shandong Province, China

    Daoliang Song, Jie Tian & Xuefeng Han

  2. Department of Laboratory Medicine, Zibo Central Hospital, No.54, Communist Youth League West Road, Zhangdian District, Zibo City, Shandong Province, China

    Xin Li

Authors
  1. Daoliang Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jie Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xuefeng Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xin Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

This research was conducted in collaboration with all authors. DS and JT performed the data curation and analysis. DS, JT and XL analyzed and interpreted the results. DS, JT and XH drafted and reviewed the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Xuefeng Han.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Ethics approval

No permissions were required to use the repository data.

Consent for publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 20 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Song, D., Tian, J., Han, X. et al. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 278, 3467–3477 (2021). https://doi.org/10.1007/s00405-020-06540-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-020-06540-4

Keywords

Search

Navigation